Doug Pace's appointment is a positive step for Dyadic's expa...

Doug Pace's appointment is a positive step for Dyadic's expansion in business development across core verticals. His biopharmaceutical expertise would facilitate Dyadic's leverage on C1 and Dapibus platforms to tap into the growing preventative, therapeutic biologic and alternative protein markets.